BIOMAT Database Logo BIOMAT Database Logo

Impact of 5-alpha reductase inhibitors on men followed by active surveillance for prostate cancer: a time-dependent covariate reanalysis. 2013

Lih-Ming Wong, and Neil Fleshner, and Antonio Finelli

UI MeSH Term Description Entries
D008297 Male Males
D011471 Prostatic Neoplasms Tumors or cancer of the PROSTATE. Cancer of Prostate,Prostate Cancer,Cancer of the Prostate,Neoplasms, Prostate,Neoplasms, Prostatic,Prostate Neoplasms,Prostatic Cancer,Cancer, Prostate,Cancer, Prostatic,Cancers, Prostate,Cancers, Prostatic,Neoplasm, Prostate,Neoplasm, Prostatic,Prostate Cancers,Prostate Neoplasm,Prostatic Cancers,Prostatic Neoplasm
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D042944 Cholestenone 5 alpha-Reductase An oxidoreductase that catalyzes the conversion of 3-oxo-delta4 steroids into their corresponding 5alpha form. It plays an important role in the conversion of TESTOSTERONE into DIHYDROTESTOSTERONE and PROGESTERONE into DIHYDROPROGESTERONE. 4-Ene Steroid 5 alpha-Reductase,5 alpha-Reductase,4 Ene Steroid 5 alpha Reductase,5 alpha Reductase,5 alpha-Reductase, Cholestenone,Cholestenone 5 alpha Reductase,alpha-Reductase, Cholestenone 5

Related Publications

Lih-Ming Wong, and Neil Fleshner, and Antonio Finelli
Re: Lih-Ming Wong, Neil Fleshner, Antonio Finelli. Impact of 5-alpha reductase inhibitors on men followed by active surveillance for prostate cancer: a Time-dependent covariate reanalysis. Eur Urol 2013;64:343.
September 2013, European urology,
Lih-Ming Wong, and Neil Fleshner, and Antonio Finelli
Impact of 5α-reductase inhibitors on men followed by active surveillance for prostate cancer.
April 2011, European urology,
Lih-Ming Wong, and Neil Fleshner, and Antonio Finelli
Utility of 5-alpha-reductase inhibitors in active surveillance for favourable risk prostate cancer.
January 2013, Canadian Urological Association journal = Journal de l'Association des urologues du Canada,
Lih-Ming Wong, and Neil Fleshner, and Antonio Finelli
Long-term use of 5-alpha-reductase inhibitors is safe and effective in men on active surveillance for prostate cancer.
March 2021, Prostate cancer and prostatic diseases,
Lih-Ming Wong, and Neil Fleshner, and Antonio Finelli
5-Alpha reductase inhibitors in active surveillance.
May 2014, Current opinion in urology,
Lih-Ming Wong, and Neil Fleshner, and Antonio Finelli
Five-alpha reductase inhibitors in men undergoing active surveillance for prostate cancer: impact on treatment and reclassification after 6 years follow-up.
September 2021, World journal of urology,
Lih-Ming Wong, and Neil Fleshner, and Antonio Finelli
Prostate cancer detection using quantitative T2 and T2 -weighted imaging: The effects of 5-alpha-reductase inhibitors in men on active surveillance.
June 2018, Journal of magnetic resonance imaging : JMRI,
Lih-Ming Wong, and Neil Fleshner, and Antonio Finelli
Impact of 5α-Reductase Inhibitors on Disease Reclassification among Men on Active Surveillance for Localized Prostate Cancer with Favorable Features.
February 2018, The Journal of urology,
Lih-Ming Wong, and Neil Fleshner, and Antonio Finelli
Prognostic influence of 5 alpha reductase inhibitors in patients with localized prostate cancer under active surveillance.
March 2018, Turkish journal of urology,
Lih-Ming Wong, and Neil Fleshner, and Antonio Finelli
The role of 5-alpha-reductase inhibitors in active surveillance.
May 2012, Current opinion in urology,
Copied contents to your clipboard!